Jeffrey J. Olson MD

Neurosurgery•Atlanta, GA

Professor, Neurosurgery, Emory University School of Medicine

Join to View Full Profile

1364 Clifton Road, NEAtlanta, GAAtlanta, GA 30322
Phone+1 404-778-5770

Education & Training

Clinical Center at the National Institutes of HealthResidency, Neurological Surgery, 1987 - 1990
University of Iowa Hospitals and ClinicsResidency, Neurological Surgery, 1981 - 1987
University of Minnesota Medical SchoolClass of 1981

Certifications & Licensure

GA State Medical License 1990 - 2025
NC State Medical License 2020 - 2022
MD State Medical License 1987 - 1991
IA State Medical License 1981 - 1988
IL State Medical License 1984 - 1987
American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
America's Top Doctors for Cancer Castle Connolly, 2006-2013
Atlanta Magazine: Top Doctors Castle Connolly, 2011
Fellow (FAANS) American Association of Neurological Surgeons
Join now to see all

Clinical Trials

Suramin in Treating Patients With Recurrent Primary Brain Tumors Start of enrollment: 1995 Jul 01
Completed
Phase 2
Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors Start of enrollment: 1999 Dec 01
Completed
Phase 1
Pharmacologic Study of Methotrexate in Patients Undergoing Stereotactic Biopsy for Recurrent High-Grade Glioma Start of enrollment: 2004 May 01
Completed
Not Applicable
A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma Start of enrollment: 2008 Aug 01
Unknown status
Phase 1, Phase 2
Assessment of Systemically Administered Torisel Delivery to Brain Tumors by Intratumoral Microdialysis Start of enrollment: 2009 Jul 01
Withdrawn
Phase 1
Trial of Temozolomide, Bevacizumab Plus Bortezomib for Recurrent Glioblastoma Multiforme Start of enrollment: 2011 Dec 01
Completed
Phase 1
Phase 0 Analysis of Ixazomib (MLN9708) in Patients With Glioblastoma Start of enrollment: 2016 Mar 24
Completed
Early Phase 1
Investigational Imaging Technique During Brain Surgery Start of enrollment: 2025 Apr 28
NOT_YET_RECRUITING
NA
Roles: Contact, Principal Investigator
Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With Glioblastoma Start of enrollment: 2023 Jul 28
RECRUITING
EARLY_PHASE1
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Risk of late radiation necrosis more than 5 years after stereotactic radiosurgery.
Neal S McCall, Annabel Lu, Benjamin D Hopkins, David Qian, Kimberly B Hoang
Journal of Neurosurgery. 2025-04-01
1 citations
Clinical and descriptive characteristics associated with high-grade meningioma in a large clinical series.
Sepideh Mokhtari, Noah C Peeri, Andre Beer-Furlan, Mark D Anderson, Sajeel Chowdhary
British Journal of Neurosurgery. 2025-04-01
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines Update for the Role of Emerging Therapies in the Management of Patients With Metastat...
Kristin Huntoon, J Bradley Elder, Guilherme Finger, D Ryan Ormond, Navid Redjal
Neurosurgery. 2025-03-17

Journal Articles

Post-Treatment Neutrophil-to-Lymphocyte Ratio Predicts for Overall Survival in Brain Metastases Treated with Stereotactic Radiosurgery
Dian Wang, Jeffrey J Olson, Jaymin Jhaveri, Walter J Curran, Robert H Press, Zachary S Buchwald, Aidnag Diaz, Philip A Blumenfeld, Gaurav Marwaha, Ross A Abrams, Kirte..., Journal of Neuro-Oncology

Authored Content

Does Size Matter? Investigating the Optimal Planning Target Volume Margin for Postoperative Stereotactic Radiosurgery to Resected Brain MetastasesApril 2018

Press Mentions

Research Roundup: Recent Grants and Publications for Emory Faculty and StaffMarch 10th, 2022
FDA Approves Emory-Developed Prostate Cancer Imaging ProbeJune 1st, 2016

Professional Memberships

Congress of Neurological Surgeons - CNS
Member
American Society of Clinical Oncology - ASCO
Member
American Association of Neurological Surgeons - AANS
Fellow
American College of Surgeons - ACS
Member